10/16/2024
3:59 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
8:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
7:59 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:00 PM | Elsbree David B (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
8:16 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
9:31 AM | Elsbree David B (Reporting)
T2 Biosystems (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
8:10 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/23/2024
3:31 PM | T2 Biosystems (Filer)
| Form 424B5 | |
08/15/2024
7:26 PM | New Dimensions Trading (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
08/15/2024
7:24 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
08/08/2024
3:49 PM | T2 Biosystems (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
11:15 PM | T2 Biosystems (Filer)
| Form EFFECT | |
07/29/2024
4:00 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:04 PM | T2 Biosystems (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/19/2024
3:16 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
11:15 PM | T2 Biosystems (Filer)
| Form EFFECT | |
05/24/2024
8:04 PM | T2 Biosystems (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2024
3:49 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
6:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:55 PM | T2 Biosystems (Filer)
| Form RW | |
05/14/2024
3:43 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:21 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D/A | |
05/13/2024
5:19 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:29 PM | T2 Biosystems (Subject)
| Form FWP | |
05/07/2024
6:46 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D/A | |
05/07/2024
3:57 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
8:38 PM | T2 Biosystems (Subject)
| Form FWP | |
05/06/2024
8:40 PM | T2 Biosystems (Subject)
| Form FWP | |
05/06/2024
4:19 PM | T2 Biosystems (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
4:24 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:27 PM | T2 Biosystems (Filer)
| Form S-1/A | |
05/06/2024
6:48 AM | T2 Biosystems (Filer)
| Form S-1/A | |
04/22/2024
4:13 PM | T2 Biosystems (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/19/2024
3:31 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D | |
04/16/2024
7:35 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:47 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:31 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
8:17 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
8:06 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
8:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:11 PM | New Dimensions Trading (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
Sell NVDA Now? (Ad) Guess who's selling NVDA next
The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). |
03/11/2024
5:14 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
03/04/2024
3:34 PM | T2 Biosystems (Filer)
| Form DEF 14A | |
02/16/2024
4:17 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:47 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
3:49 PM | T2 Biosystems (Filer)
| Form PRE 14A | |
02/13/2024
7:15 PM | Lind Global Fund II LP (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
11/28/2023
3:00 PM | Giffin Brett A. (Reporting)
T2 Biosystems (Issuer)
| Form 4/A | |
11/24/2023
3:30 PM | T2 Biosystems (Filer)
| Form 8-K/A | |
11/14/2023
6:33 PM | T2 Biosystems (Filer)
| Form NT 10-Q | |
11/01/2023
8:08 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
